10-hydroxycamptothecin has been researched along with chitosan in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ding, Y; Ping, Q; Yu, LL; Zhang, C | 1 |
Du, YZ; Hu, FQ; Wang, L; Yuan, H; Zhou, JP; Zhou, YY | 1 |
Huang, F; Jing, GL; Qu, JB; Shao, HH | 1 |
Cao, J; Cui, S; Gu, Y; Qian, Z; Zhu, H | 1 |
Ge, L; Wang, J; Wang, Y; Xu, H; Zhu, J | 1 |
Fan, Z; Hou, Z; Jiang, Y; Li, Y; Lu, Y; Wu, S; Yang, X | 1 |
Li, J; Oupický, D; Ping, Q; Qiao, H; Su, Z; Sun, M; Xie, Y; Zhang, C | 1 |
7 other study(ies) available for 10-hydroxycamptothecin and chitosan
Article | Year |
---|---|
Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives.
Topics: Camptothecin; Chitosan; Chromatography, High Pressure Liquid; Drug Delivery Systems; Drug Stability; Hydrophobic and Hydrophilic Interactions; Micelles; Microscopy, Electron, Transmission; Molecular Structure; Particle Size; Pharmaceutical Preparations; Solubility | 2007 |
Preparation and pharmacodynamics of stearic acid and poly (lactic-co-glycolic acid) grafted chitosan oligosaccharide micelles for 10-hydroxycamptothecin.
Topics: Antineoplastic Agents, Phytogenic; Biological Transport; Camptothecin; Carbodiimides; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactic Acid; Magnetic Resonance Spectroscopy; Micelles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Stearic Acids; Technology, Pharmaceutical | 2010 |
PEG-chitosan-coated iron oxide nanoparticles with high saturated magnetization as carriers of 10-hydroxycamptothecin: preparation, characterization and cytotoxicity studies.
Topics: Camptothecin; Cell Survival; Chitosan; Drug Carriers; Ferric Compounds; Hep G2 Cells; Humans; Nanoparticles; Polyethylene Glycols | 2013 |
Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Mice; Mice, Nude; Micelles; Neoplasms; Rats | 2013 |
Investigation of dual-sensitive nanogels based on chitosan and N-isopropylacrylamide and its intelligent drug delivery of 10-hydroxycamptothecine.
Topics: Acrylamides; Acrylic Resins; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line; Chitosan; Drug Delivery Systems; Drug Liberation; Dynamic Light Scattering; Gels; Humans; Hydrogen-Ion Concentration; Molecular Weight; Technology, Pharmaceutical; Temperature | 2015 |
A green approach to dual-drug nanoformulations with targeting and synergistic effects for cancer therapy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Camptothecin; Cell Survival; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Combinations; Drug Compounding; Drug Stability; Drug Synergism; Female; Green Chemistry Technology; HeLa Cells; Humans; Methotrexate; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nanoparticles; Solubility; Technology, Pharmaceutical; Tissue Distribution; Tumor Burden; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Arginine-Modified Nanostructured Lipid Carriers with Charge-Reversal and pH-Sensitive Membranolytic Properties for Anticancer Drug Delivery.
Topics: Animals; Antineoplastic Agents; Arginine; Camptothecin; Chitosan; Drug Carriers; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms, Experimental; Male; Mice; Nanostructures; Rats; Rats, Sprague-Dawley; Xenograft Model Antitumor Assays | 2017 |